PWP
XBI icon

Pursue Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pursue Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,679
Closed -$1.42M – 114
2025
Q4 		$1.42M Buy
11,679
+646
+6% +$74.1K 0.69% 36
2025
Q3 		$1.11M Sell
11,033
-452
-4% -$40.7K 0.61% 45
2025
Q2 		$952K Buy
11,485
+537
+5% +$42.8K 0.54% 46
2025
Q1 		$888K Sell
10,948
-3,856
-26% -$345K 0.54% 48
2024
Q4 		$1.33M Hold
14,804
– – 0.76% 39
2024
Q3 		$1.46M Buy
14,804
+1,227
+9% +$121K 0.8% 34
2024
Q2 		$1.26M Buy
13,577
+3,395
+33% +$304K 0.69% 36
2024
Q1 		$966K Sell
10,182
-3,664
-26% -$340K 0.57% 44
2023
Q4 		$1.24M Buy
13,846
+2,060
+17% +$153K 0.8% 33
2023
Q3 		$861K Sell
11,786
-8,675
-42% -$693K 0.61% 42
2023
Q2 		$1.7M Sell
20,461
-2,083
-9% -$174K 1.07% 29
2023
Q1 		$1.72M Sell
22,544
-3,683
-14% -$306K 1.17% 32
2022
Q4 		$2.18M Sell
26,227
-4,058
-13% -$329K 1.68% 18
2022
Q3 		$2.4M Sell
30,285
-450
-1% -$37.9K 1.73% 16
2022
Q2 		$2.28M Buy
30,735
+2,951
+11% +$222K 1.45% 22
2022
Q1 		$2.57M Buy
27,784
+11,379
+69% +$1.05M 1.06% 25
2021
Q4 		$1.84M Buy
+16,405
New +$1.98M 0.71% 38

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pursue Wealth Partners's XBI Position: Q1 2026 in Review

Pursue Wealth Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 11,679 shares — an estimated $1.42M sold.

Pursue Wealth Partners first reported a position in XBI in Q4 2021 and held it in 17 quarters. The position peaked at $2.57M in Q1 2022. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Pursue Wealth Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • Pursue Wealth Partners sold 11,679 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.42M.
  • Pursue Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 17 quarters.
  • Pursue Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $2.57M in Q1 2022.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Pursue Wealth Partners's 13F filing for Q1 2026, filed 8 Apr 2026.